Keywords: Dementia, Dementia
Motivation: Currently, MRI does not provide AD-specific metrics while PET has AD-specific tracers for amyloid-beta and tau. Diffusion MRI-derived metrics may supply additional information on AD pathology and simplify clinical management.
Goal(s): To determine if the changes in diffusion MR are related to amyloid, tau, metabolic AD pathology assessed by PET.
Approach: We used existing image database for AD patients and controls that has multi-shell diffusion MRI and AV45, tau, FDG PET. A multi-compartment diffusion model was used to assess disease pathology.
Results: Decreased restricted diffusion is associated with increased tau and decreased metabolism.
Impact: Accurate diagnosis and monitoring disease progression of AD patients using diffusion MRI will improve clinical management of AD patients. Particularly, the AD patients undergoing drug therapy and regular MRI scans will benefit.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords